LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

Home・Aandelen Lijst・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Gesloten

SectorGezondheidszorg

431.57 0.22

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

417.04

Max

432.91

Belangrijke statistieken
By Trading Economics
Inkomsten	56M -59M
Verkoop	34M 321M
Winstmarge	-18.243
Werknemers	915
EBITDA	56M -50M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+60.55% upside

Dividenden
By Dow Jones
Volgende Winsten	30 apr 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-661M 9.9B
Vorige openingsprijs	431.35
Vorige sluitingsprijs	431.57

Nieuwssentiment

By Acuity

45%

55%

136 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

263.2 / 277.1 Steun & Weerstand

Madrigal Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 mrt 2026, 18:13 UTC

Acquisities, Fusies, Overnames

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9 mrt 2026, 17:20 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9 mrt 2026, 17:15 UTC

Acquisities, Fusies, Overnames

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10 mrt 2026, 00:00 UTC

Belangrijke Nieuwsgebeurtenissen

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9 mrt 2026, 23:52 UTC

Marktinformatie

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9 mrt 2026, 23:50 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

9 mrt 2026, 23:46 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Correction to Crude Prices Market Talk on March 9

9 mrt 2026, 23:42 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9 mrt 2026, 23:08 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9 mrt 2026, 23:07 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9 mrt 2026, 21:29 UTC

Acquisities, Fusies, Overnames

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9 mrt 2026, 21:28 UTC

Acquisities, Fusies, Overnames

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

9 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

9 mrt 2026, 20:47 UTC

Belangrijke Nieuwsgebeurtenissen

The 24 Hours When Oil Markets Went Wild -- WSJ

9 mrt 2026, 20:33 UTC

Belangrijke Nieuwsgebeurtenissen

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9 mrt 2026, 20:14 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9 mrt 2026, 19:33 UTC

Belangrijke Nieuwsgebeurtenissen

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9 mrt 2026, 19:17 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9 mrt 2026, 19:14 UTC

Marktinformatie

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9 mrt 2026, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

9 mrt 2026, 18:23 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9 mrt 2026, 17:58 UTC

Acquisities, Fusies, Overnames

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9 mrt 2026, 17:57 UTC

Acquisities, Fusies, Overnames

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9 mrt 2026, 17:41 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9 mrt 2026, 17:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9 mrt 2026, 17:08 UTC

Marktinformatie

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9 mrt 2026, 17:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

9 mrt 2026, 17:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Peer Vergelijking

Prijswijziging

Madrigal Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

60.55% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 694.9 USD 60.55%

Hoogste 964 USD

Laagste 529 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Madrigal Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan Madrigal Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

263.2 / 277.1Steun & Weerstand

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

136 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.